Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation

Affiliations

• ¹ Department of Transplantation and Cell Therapy, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
• ² Department of Pediatric Hematology and Oncology Research, National Research Center for Child Health and Development, Tokyo, Japan.
• ³ Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
• ⁴ Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
• ⁵ Department of Oncology/Hematology, Shimane University, Izumo, Japan.
• ⁶ Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
• ⁷ Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
• ⁸ Department of Hematology, Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital, Hiroshima, Japan.
• ⁹ Department of Hematology, Chiba University, Chiba, Japan.
• ¹⁰ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
• ¹¹ Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan.
• ¹² Division of Hematology, National Defense Medical College, Tokorozawa, Japan.
• ¹³ Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
• ¹⁴ Department of Pediatrics, Osaka University Hospital, Suita, Japan.
• ¹⁵ Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
• ¹⁶ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
• ¹⁷ Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ¹⁸ Department of Hematology, Toranomon Hospital, Tokyo, Japan.